|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18381794 PMID:20563569 PMID:21064136 PMID:24502637 PMID:25007187 PMID:28193520 PMID:32387182 More...
|
|
NCBI chrNW_004936763:1,225,355...1,308,257
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18256692 |
|
NCBI chrNW_004936501:3,400,971...3,467,061
|
|
G |
Abcc12 |
ATP binding cassette subfamily C member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chrNW_004936475:1,331,887...1,391,535
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20216337 PMID:23222202 PMID:25007187 PMID:32387182 |
|
NCBI chrNW_004936636:292,631...341,999
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23222202 |
|
NCBI chrNW_004936472:14,396,986...14,624,597
|
|
G |
Ache |
acetylcholinesterase (Cartwright blood group) |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27083141 |
|
NCBI chrNW_004936543:856,678...862,080
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15641640 |
|
NCBI chrNW_004936567:1,430,128...1,508,626
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15641640 |
|
NCBI chrNW_004936619:597,970...618,564
|
|
G |
Ahsg |
alpha 2-HS glycoprotein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936578:3,332,934...3,339,903
|
|
G |
Apob |
apolipoprotein B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31186542 |
|
NCBI chrNW_004936493:10,509,118...10,549,144
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24712521 |
|
NCBI chrNW_004936614:1,072,263...1,252,573
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
|
ISO |
protein:increased expression:plasma (rat) |
RGD |
PMID:20544730 |
RGD:4140449 |
NCBI chrNW_004936487:17,482,307...17,527,407
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16947783 |
|
NCBI chrNW_004936586:1,782,581...1,809,458
|
|
G |
B2m |
beta-2-microglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936471:7,646,504...7,655,656
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:3111302 |
|
NCBI chrNW_004936707:1,784,338...1,913,401
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30552955 |
|
NCBI chrNW_004936694:2,702,224...2,724,574
|
|
G |
Camk2n1 |
calcium/calmodulin dependent protein kinase II inhibitor 1 |
|
ISO |
associated with colon cancer |
RGD |
PMID:22020760 |
RGD:15097511 |
NCBI chrNW_004936474:6,463,691...6,466,641
|
|
G |
Cda |
cytidine deaminase |
|
ISO |
DNA:SNP:cds:rs1048977|rs12726436|rs2072671 (human) |
RGD |
PMID:28347776 |
RGD:152995291 |
NCBI chrNW_004936474:6,543,295...6,564,575
|
|
G |
Ces2 |
carboxylesterase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19931604 |
|
NCBI chrNW_004936475:17,452,749...17,460,880
|
|
G |
Clu |
clusterin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24361871 PMID:28885000 |
|
NCBI chrNW_004936675:499,745...513,515
|
|
G |
Commd1 |
copper metabolism domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23583003 |
|
NCBI chrNW_004936491:7,247,160...7,421,039
|
|
G |
Csf2 |
colony stimulating factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7960606 |
|
NCBI chrNW_004936647:3,081,896...3,083,864
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:7692001 PMID:27737899 PMID:31557154 |
|
NCBI chrNW_004936490:15,142,526...15,146,375
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 |
|
NCBI chrNW_004936469:67,962...83,116
|
|
G |
Dip2b |
disco interacting protein 2 homolog B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936512:8,131,304...8,370,519
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
ISO |
DNA:SNP:cds:rs12119882 (human) |
RGD |
PMID:28347776 |
RGD:152995291 |
NCBI chrNW_004936537:1,660,461...2,439,305
|
|
G |
Enosf1 |
enolase superfamily member 1 |
|
ISO |
DNA:SNP:cds:rs699517 (human) |
RGD |
PMID:28347776 |
RGD:152995291 |
NCBI chrNW_004936550:12,899...31,390
|
|
G |
Epha7 |
EPH receptor A7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30357299 |
|
NCBI chrNW_004936812:698,548...865,589
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26165641 |
|
NCBI chrNW_004936675:350,357...392,919
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
treatment |
ISO |
associated with Leukemia, Myeloid, Acute associated with Breast Neoplasms;DNA:SNP: :p.Q504K (human) |
RGD |
PMID:17197435 PMID:25495407 |
RGD:11252168 RGD:11252178 |
NCBI chrNW_004936706:1,854,938...1,867,521
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
treatment |
ISO |
DNA:SNP: :p.K751Q (rs13181) (human) associated with Leukemia, Myeloid, Acute;DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human) |
RGD |
PMID:15339847 PMID:17197435 |
RGD:11252178 RGD:11252202 |
NCBI chrNW_004936706:1,816,561...1,829,638
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936593:311,245...638,625
|
|
G |
Gata4 |
GATA binding protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31190750 |
|
NCBI chrNW_004936675:3,408,549...3,420,828
|
|
G |
Gata6 |
GATA binding protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31190750 |
|
NCBI chrNW_004936550:1,814,336...1,844,399
|
|
G |
Gc |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936598:3,220,029...3,256,091
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 PMID:24361871 PMID:28885000 |
|
NCBI chrNW_004936515:6,030,402...6,051,161
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27474498 |
|
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18227147 |
|
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Homer1 |
homer scaffold protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24126708 |
|
NCBI chrNW_004936549:7,189,588...7,320,117
|
|
G |
Hpx |
hemopexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936842:485,515...495,684
|
|
G |
Hspb6 |
heat shock protein family B (small) member 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18948619 |
|
NCBI chrNW_004936570:568,708...571,099
|
|
G |
Htr2b |
5-hydroxytryptamine receptor 2B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16863450 |
|
NCBI chrNW_004936525:5,711,894...5,729,074
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20064577 |
|
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Igfbp1 |
insulin like growth factor binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chrNW_004936478:20,494,190...20,499,001
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Il3 |
interleukin 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8202718 |
|
NCBI chrNW_004936647:3,102,922...3,104,758
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:1720698 |
|
NCBI chrNW_004936507:5,566,144...5,650,412
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936487:15,721,752...15,725,396
|
|
G |
LOC101961588 |
cytochrome P450 2D17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23609392 |
|
NCBI chrNW_004936718:153,340...157,966
|
|
G |
LOC101962856 |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936519:6,431,156...6,473,183
|
|
G |
LOC101964975 |
interleukin-8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936598:1,779,471...1,781,353
|
|
G |
LOC101969421 |
cytochrome P450 1A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10445756 |
|
NCBI chrNW_004936471:33,704,616...33,709,455
|
|
G |
LOC101970831 |
serotransferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936529:6,917,762...6,947,512
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18990727 |
|
NCBI chrNW_004936486:19,691,822...19,702,684
|
|
G |
LOC101976131 |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936487:3,399,792...3,412,088
|
|
G |
LOC101976500 |
haptoglobin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G |
Ltbr |
lymphotoxin beta receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936709:1,362,846...1,369,287
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
susceptibility |
ISO |
associated with lung non-small cell carcinoma;DNA:SNP:3' utr, intron: (rs3804451) (human) |
RGD |
PMID:26993769 |
RGD:151665351 |
NCBI chrNW_004936476:23,237,762...23,310,211
|
|
G |
Mocos |
molybdenum cofactor sulfurase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29935280 |
|
NCBI chrNW_004936517:9,059,042...9,105,304
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15753437 PMID:16166815 PMID:17387702 PMID:17502830 PMID:18551038 PMID:19159907 PMID:19391036 PMID:19821069 PMID:21064136 PMID:25007187 PMID:26077125 More...
|
|
NCBI chrNW_004936474:623,438...637,849
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15753437 PMID:19159907 |
|
NCBI chrNW_004936484:16,087,924...16,180,089
|
|
G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 |
|
NCBI chrNW_004936643:379,790...410,034
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20605904 |
|
NCBI chrNW_004936509:6,589,967...6,621,171
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3 group C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29802709 |
|
NCBI chrNW_004936504:10,960,069...11,056,834
|
|
G |
Nt5c2 |
5'-nucleotidase, cytosolic II |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936600:2,828,277...2,892,795
|
|
G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936491:8,985,074...9,040,863
|
|
G |
Plg |
plasminogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936489:11,775,243...11,808,482
|
|
G |
Plk2 |
polo like kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12897130 |
|
NCBI chrNW_004936480:9,680,461...9,686,593
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19683050 |
|
NCBI chrNW_004936629:3,672,445...3,725,645
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10698006 |
|
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Ren |
renin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8723173 |
|
NCBI chrNW_004936567:598,044...607,628
|
|
G |
Shmt1 |
serine hydroxymethyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 |
|
NCBI chrNW_004936741:1,849,239...1,877,724
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21064136 |
|
NCBI chrNW_004936778:823,376...846,843
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
|
ISO |
DNA:SNP:cds:rs2270860|rs4149178 (human) |
RGD |
PMID:28347776 |
RGD:152995291 |
NCBI chrNW_004936476:16,675,377...16,680,209
|
|
G |
Slc34a2 |
solute carrier family 34 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chrNW_004936477:3,954,377...3,975,259
|
|
G |
Slco2a1 |
solute carrier organic anion transporter family member 2A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chrNW_004936529:7,069,003...7,155,229
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936500:10,345,154...10,352,873
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15805072 |
|
NCBI chrNW_004936905:148,956...156,023
|
|
G |
Tcn2 |
transcobalamin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15753437 |
|
NCBI chrNW_004936904:97,535...113,886
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27474498 |
|
NCBI chrNW_004936620:2,563,900...2,568,117
|
|
G |
Tlr1 |
toll like receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chrNW_004936482:6,582,430...6,591,128
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 PMID:31557154 |
|
NCBI chrNW_004936576:522,234...531,660
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31557154 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Top1 |
DNA topoisomerase I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19931604 |
|
NCBI chrNW_004936561:641,451...723,323
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9369336 |
|
NCBI chrNW_004936595:919,807...935,367
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28885000 |
|
NCBI chrNW_004936682:1,628,489...1,635,495
|
|
G |
Txn |
thioredoxin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11462148 |
|
NCBI chrNW_004936559:2,811,786...2,822,528
|
|
G |
Tyms |
thymidylate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP:cds:rs2853741 (human) |
CTD RGD |
PMID:19648163 PMID:21064136 PMID:25007187 PMID:26077125 PMID:28347776 |
RGD:152995291 |
NCBI chrNW_004936550:33,797...42,233
|
|
G |
Umps |
uridine monophosphate synthetase |
|
ISO |
DNA:SNP:cds:rs2279199|rs4678145 (human) |
RGD |
PMID:28347776 |
RGD:152995291 |
NCBI chrNW_004936725:553,278...564,846
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31068094 |
|
NCBI chrNW_004936476:16,245,134...16,261,180
|
|
G |
Vkorc1 |
vitamin K epoxide reductase complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26445138 |
|
NCBI chrNW_004936501:13,459,400...13,461,864
|
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
susceptibility |
ISO |
DNA:missense mutation:cds:p.G671V (human) |
RGD |
PMID:16330681 |
RGD:11041175 |
NCBI chrNW_004936763:1,225,355...1,308,257
|
|
G |
Capn2 |
calpain 2 |
treatment |
ISO |
|
RGD |
PMID:25634181 |
RGD:13792617 |
NCBI chrNW_004936526:879,765...932,682
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
|
ISO |
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) |
RGD |
PMID:24284041 |
RGD:11252190 |
NCBI chrNW_004936706:1,816,561...1,829,638
|
|
|
G |
Cacng6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
susceptibility |
ISO |
DNA:SNP,haplotype:rs192808(human) |
RGD |
PMID:20860846 |
RGD:13524562 |
NCBI chrNW_004936994:158,621...171,597
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20022477 PMID:20485159 |
RGD:4145619 |
NCBI chrNW_004936596:223,660...224,739
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 PMID:17641958 PMID:20485159 |
|
NCBI chrNW_004936547:479,261...504,757
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human) |
CTD RGD |
PMID:15970796 PMID:16502481 PMID:20485159 |
RGD:5144000 |
NCBI chrNW_004936565:1,917,970...1,919,027
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
DNA:haplotype::rs4647416(human) |
RGD |
PMID:21670957 |
RGD:11045795 |
NCBI chrNW_004936626:3,980,311...4,147,042
|
|
G |
LOC101963197 |
HLA class II histocompatibility antigen, DP beta 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004936476:25,730,800...25,741,089
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 |
|
NCBI chrNW_004936739:975,494...978,426
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004936581:2,743,133...2,751,925
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chrNW_004936472:31,644,778...31,677,572
|
|
G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004936581:2,069,355...2,072,535
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to |
ClinVar |
PMID:15496426 |
|
NCBI chrNW_004936697:2,440,943...2,453,897
|
|
G |
Ptgir |
prostaglandin I2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004936664:487,069...489,328
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:mast cell |
CTD RGD |
PMID:9487340 PMID:16502481 PMID:20485159 |
RGD:5143936 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
|
ISO |
|
RGD |
PMID:21796142 |
RGD:5147839 |
NCBI chrNW_004936476:25,913,699...25,923,419
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to |
ClinVar |
PMID:15806396 |
|
NCBI chrNW_004936490:13,546,405...13,558,635
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :795T>C (human) |
CTD RGD |
PMID:15898979 PMID:16502481 PMID:20485159 |
RGD:11059537 |
NCBI chrNW_004936588:2,040,712...2,044,635
|
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
ClinVar |
PMID:17959182 PMID:21558275 PMID:30643255 |
|
NCBI chrNW_004936677:3,232,183...3,241,307
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936697:2,440,943...2,453,897
|
|
G |
Tbx21 |
T-box transcription factor 21 |
|
ISO |
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance |
OMIM ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936490:13,546,405...13,558,635
|
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33676887 |
|
NCBI chrNW_004936484:19,713,299...19,721,144
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:26145887 |
|
NCBI chrNW_004936707:1,784,338...1,913,401
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29800642 |
|
NCBI chrNW_004936485:12,428,765...12,439,570
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chrNW_004936704:1,372,137...1,393,355
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34713381 |
|
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34713381 |
|
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Hbegf |
heparin binding EGF like growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chrNW_004936531:9,332,939...9,345,039
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32068018 |
|
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
LOC101964975 |
interleukin-8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chrNW_004936598:1,779,471...1,781,353
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34648132 |
|
NCBI chrNW_004936869:568,324...589,972
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) |
RGD |
PMID:26345518 |
RGD:11533645 |
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chrNW_004936474:683,325...684,662
|
|
G |
Nrg1 |
neuregulin 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29305325 |
|
NCBI chrNW_004936766:1,104,841...1,306,368
|
|
G |
Rac1 |
Rac family small GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28710503 |
|
NCBI chrNW_004936750:107,689...122,679
|
|
G |
Rarg |
retinoic acid receptor gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26237429 |
|
NCBI chrNW_004936512:10,502,954...10,524,796
|
|
G |
Sirt6 |
sirtuin 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34713381 |
|
NCBI chrNW_004936588:2,387,162...2,394,066
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 |
|
NCBI chrNW_004936576:522,234...531,660
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29959987 PMID:32068018 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30009776 PMID:34713381 |
|
NCBI chrNW_004936595:919,807...935,367
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936605:3,135,977...3,190,956
|
|
G |
Abcb1 |
ATP binding cassette subfamily B member 1 |
severity susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:SNP::2677G>T/A(rs2032582)(human) |
CTD RGD |
PMID:20623750 PMID:26134275 PMID:27296832 |
RGD:11041130 RGD:14700895 |
NCBI chrNW_004936763:1,225,355...1,308,257
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
severity |
ISO |
DNA:SNP: :rs2287616(human) |
RGD |
PMID:27293027 |
RGD:14402413 |
NCBI chrNW_004936469:10,521,576...10,599,005
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18466103 |
|
NCBI chrNW_004936501:3,400,971...3,467,061
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
DNA:polymorphism:promoter:-24C>T(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17241877 PMID:18381794 PMID:18466103 PMID:25196354 |
RGD:14700812 RGD:14700814 |
NCBI chrNW_004936636:292,631...341,999
|
|
G |
Abi1 |
abl interactor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936484:2,090,605...2,194,109
|
|
G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936477:19,696,274...19,731,338
|
|
G |
Acsl1 |
acyl-CoA synthetase long chain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936554:4,425,518...4,484,853
|
|
G |
Actb |
actin beta |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver |
CTD RGD |
PMID:22563491 PMID:25231249 |
RGD:9587759 |
NCBI chrNW_004936765:667,107...670,627
|
|
G |
Actn4 |
actinin alpha 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936801:1,333,077...1,402,885
|
|
G |
Actr3 |
actin related protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936469:55,639,345...55,699,330
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:21161045 |
RGD:5128859 |
NCBI chrNW_004936530:2,217,713...2,224,070
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24646716 |
|
NCBI chrNW_004936486:19,389,925...19,403,577
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20709802 |
|
NCBI chrNW_004936578:3,168,599...3,179,369
|
|
G |
Adipor2 |
adiponectin receptor 2 |
severity |
ISO |
associated with obesity, LPS;mRNA:decreased expression:liver (rat) |
RGD |
PMID:23838384 |
RGD:8695926 |
NCBI chrNW_004936606:1,911,104...2,007,109
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29499335 |
|
NCBI chrNW_004936484:19,713,299...19,721,144
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21890736 PMID:34848246 |
|
NCBI chrNW_004936546:3,737,908...3,783,492
|
|
G |
Aifm1 |
apoptosis inducing factor mitochondria associated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25743375 |
|
NCBI chrNW_004936479:1,441,508...1,477,133
|
|
G |
Ak4 |
adenylate kinase 4 |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:16538043 |
RGD:2301096 |
NCBI chrNW_004936692:2,593,409...2,654,583
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:29763686 PMID:32805337 |
RGD:27226688 |
NCBI chrNW_004936474:26,680,736...26,696,996
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family member L2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936492:9,605,611...9,657,717
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
severity susceptibility |
ISO |
DNA:deletion:exon 3 (mouse) protein:increased expression:liver |
RGD |
PMID:21138988 PMID:24492981 PMID:30121625 |
RGD:14975148 RGD:15036810 RGD:7241599 |
NCBI chrNW_004936558:4,362,693...4,387,705
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936481:19,630,045...19,650,009
|
|
G |
Aldob |
aldolase, fructose-bisphosphate B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16115720 |
|
NCBI chrNW_004936524:9,584,302...9,592,961
|
|
G |
Anxa2 |
annexin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936471:21,274,112...21,329,286
|
|
G |
Anxa6 |
annexin A6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936647:3,978,047...4,029,485
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936542:2,111,055...2,112,626
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
Apoh |
apolipoprotein H |
|
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:plasma: |
CTD RGD |
PMID:16099942 PMID:23288050 |
RGD:10054107 |
NCBI chrNW_004936541:6,683,483...6,695,094
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20935161 |
|
NCBI chrNW_004936580:1,038,420...1,093,319
|
|
G |
Atg5 |
autophagy related 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22491424 |
|
NCBI chrNW_004936564:2,759,085...2,885,394
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936712:1,529,508...1,552,148
|
|
G |
Atp6v1d |
ATPase H+ transporting V1 subunit D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
|
|
G |
Bad |
BCL2 associated agonist of cell death |
treatment |
ISO |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chrNW_004936599:4,924,349...4,933,683
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17906064 |
|
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bdh1 |
3-hydroxybutyrate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936833:367,790...409,966
|
|
G |
Bdkrb2 |
bradykinin receptor B2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30685357 |
|
NCBI chrNW_004936604:548,844...551,031
|
|
G |
Blvrb |
biliverdin reductase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936661:2,808,998...2,818,123
|
|
G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936650:2,113,933...2,138,487
|
|
G |
Brd4 |
bromodomain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936596:5,176,682...5,246,102
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Ca3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 PMID:25231249 |
|
NCBI chrNW_004936544:337,437...347,760
|
|
G |
Cabp1 |
calcium binding protein 1 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chrNW_004936668:324,299...339,334
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936605:2,505,064...3,012,322
|
|
G |
Canx |
calnexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936739:1,051,853...1,085,658
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936474:21,854,454...21,881,622
|
|
G |
Casp8 |
caspase 8 |
treatment |
ISO |
|
RGD |
PMID:25447754 |
RGD:10053709 |
NCBI chrNW_004936726:554,627...596,334
|
|
G |
Cast |
calpastatin |
|
ISO |
|
RGD |
PMID:16871587 |
RGD:5683869 |
NCBI chrNW_004936523:6,688,153...6,798,184
|
|
G |
Cat |
catalase |
|
ISO |
protein:decreased expression:liver CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:20623750 PMID:21138988 PMID:25231249 |
RGD:7241599 |
NCBI chrNW_004936533:3,601,270...3,637,128
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936536:294,650...330,875
|
|
G |
Cct3 |
chaperonin containing TCP1 subunit 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936580:5,537,338...5,554,384
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936643:2,354,799...2,368,048
|
|
G |
Cdc25b |
cell division cycle 25B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936485:14,897,050...14,914,034
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936738:160,346...227,687
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936512:8,901,674...8,919,819
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936475:10,011,671...10,023,643
|
|
G |
Chrm3 |
cholinergic receptor muscarinic 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20197374 |
|
NCBI chrNW_004936484:13,953,141...14,373,174
|
|
G |
Ckb |
creatine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936621:1,612,398...1,615,821
|
|
G |
Clu |
clusterin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936675:499,745...513,515
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936470:26,440,606...26,643,015
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16679477 |
|
NCBI chrNW_004936506:8,886,494...8,923,921
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:21138988 |
RGD:7241599 |
NCBI chrNW_004936619:3,847,059...3,883,866
|
|
G |
Coq9 |
coenzyme Q9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936475:9,502,638...9,517,601
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
ISO |
mRNA,protein:increased expression,increased activity:liver,plasma |
RGD |
PMID:19386599 |
RGD:7243112 |
NCBI chrNW_004936857:577,067...609,855
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936586:5,739,038...5,850,317
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20005281 |
|
NCBI chrNW_004936490:15,142,526...15,146,375
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:19679878 |
|
NCBI chrNW_004936473:29,999,542...30,034,610
|
|
G |
Ctse |
cathepsin E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936557:6,485,783...6,498,805
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11739529 |
|
NCBI chrNW_004936676:60,869...63,028
|
|
G |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936748:342,655...386,017
|
|
G |
Ddb1 |
damage specific DNA binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936581:1,710,382...1,742,598
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936498:4,514,212...4,544,523
|
|
G |
Dhfr |
dihydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19648163 |
|
NCBI chrNW_004936469:67,962...83,116
|
|
G |
Dlat |
dihydrolipoamide S-acetyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936612:2,395,452...2,437,592
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936653:1,554,534...1,558,832
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936521:10,360,775...10,403,201
|
|
G |
Dsc2 |
desmocollin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936682:2,057,331...2,091,034
|
|
G |
E2f1 |
E2F transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chrNW_004936561:6,894,827...6,901,058
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936639:2,351,777...2,394,539
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936486:19,488,619...19,496,583
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936577:4,486,617...4,516,379
|
|
G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25411909 |
|
NCBI chrNW_004936750:389,913...430,783
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936521:8,182,740...8,207,466
|
|
G |
Endog |
endonuclease G |
|
ISO |
protein:decreased expression:mitochondrion: |
RGD |
PMID:22509279 |
RGD:9685364 |
NCBI chrNW_004936487:16,282,115...16,285,486
|
|
G |
Eng |
endoglin |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:21146604 |
RGD:7257529 |
NCBI chrNW_004936487:15,467,165...15,499,180
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 PMID:25231249 |
|
NCBI chrNW_004936623:3,115,357...3,130,289
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
ISO |
protein:increased activity:serum: |
RGD |
PMID:17850827 |
RGD:9685426 |
NCBI chrNW_004936470:26,994,549...27,099,758
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936526:2,589,254...2,652,831
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936491:351,813...377,978
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30538632 |
|
NCBI chrNW_004936541:4,613,197...4,705,911
|
|
G |
F13a1 |
coagulation factor XIII A chain |
|
ISO |
|
RGD |
PMID:22019897 |
RGD:11041813 |
NCBI chrNW_004936534:6,199,066...6,360,374
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407844 |
|
NCBI chrNW_004936537:4,637,028...4,647,915
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO |
|
RGD |
PMID:25447754 PMID:26062544 |
RGD:10053709 RGD:11341803 |
NCBI chrNW_004936599:633,501...639,412
|
|
G |
Fads1 |
fatty acid desaturase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936581:1,312,199...1,327,046
|
|
G |
Fads2 |
fatty acid desaturase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936581:1,203,410...1,233,330
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:16831245 |
RGD:8662853 |
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936594:5,591,785...5,609,886
|
|
G |
Fcmr |
Fc fragment of IgM receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936557:5,707,138...5,718,192
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chrNW_004936576:1,322,406...1,329,743
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
severity |
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:29883717 |
RGD:15045603 |
NCBI chrNW_004936664:2,826,823...2,828,330
|
|
G |
Flt1 |
fms related receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21135413 |
|
NCBI chrNW_004936472:23,442,946...23,617,523
|
|
G |
Ftl |
ferritin light chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936664:2,976,325...2,977,878
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
|
ISO |
mRNA:decreased expression:liver (mouse) |
RGD |
PMID:28189721 |
RGD:14695531 |
NCBI chrNW_004936490:17,605,865...17,614,754
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:21864513 |
RGD:10449168 |
NCBI chrNW_004936809:1,269,900...1,285,853
|
|
G |
Gadd45a |
growth arrest and DNA damage inducible alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936591:3,998,359...4,001,491
|
|
G |
Ganab |
glucosidase II alpha subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936581:613,292...633,075
|
|
G |
Gc |
GC vitamin D binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936598:3,220,029...3,256,091
|
|
G |
Gclc |
glutamate-cysteine ligase catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17573345 PMID:19481141 |
RGD:10402383 |
NCBI chrNW_004936476:7,371,270...7,418,756
|
|
G |
Gda |
guanine deaminase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936503:8,191,925...8,279,806
|
|
G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936809:1,188,793...1,194,816
|
|
G |
Gfer |
growth factor, augmenter of liver regeneration |
treatment |
ISO |
|
RGD |
PMID:15968720 PMID:22033404 |
RGD:9685722 RGD:9685727 |
NCBI chrNW_004936694:2,051,362...2,053,812
|
|
G |
Ggh |
gamma-glutamyl hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21219404 |
|
NCBI chrNW_004936496:10,485,528...10,505,506
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
ISO |
|
RGD |
PMID:10934156 |
RGD:14701049 |
NCBI chrNW_004936619:762,278...791,610
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33483742 |
|
NCBI chrNW_004936601:5,415,857...5,435,964
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936636:617,376...640,424
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936512:7,762,325...7,770,007
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum: |
CTD RGD |
PMID:145039 PMID:19085960 PMID:19481104 PMID:21772750 PMID:27293452 PMID:28487901 More...
|
RGD:14975162 RGD:14975166 RGD:14975168 RGD:14975249 |
NCBI chrNW_004936470:7,765,810...7,770,837
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
|
ISO |
protein:increased expression, activity:serum: |
RGD |
PMID:19085960 |
RGD:14975249 |
NCBI chrNW_004936475:262,558...299,766
|
|
G |
Gsn |
gelsolin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936487:9,749,755...9,802,787
|
|
G |
Gsr |
glutathione-disulfide reductase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver |
RGD CTD |
PMID:23554813 PMID:24154663 PMID:25226513 PMID:28069987 |
RGD:10401878 RGD:7257532 |
NCBI chrNW_004936792:531,076...579,083
|
|
G |
Gstm3 |
glutathione S-transferase mu 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25743375 |
|
NCBI chrNW_004936704:1,233,909...1,236,864
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936600:1,932,152...1,943,342
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:25226513 |
|
NCBI chrNW_004936599:2,197,681...2,200,642
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936473:2,823,183...2,856,077
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936493:6,182,786...6,224,601
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936627:4,167,501...4,179,596
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936515:6,030,402...6,051,161
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19783637 PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898 |
RGD:10762620 RGD:15090820 |
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936691:650,753...694,362
|
|
G |
Hpx |
hemopexin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936842:485,515...495,684
|
|
G |
Hrh2 |
histamine receptor H2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22926047 |
|
NCBI chrNW_004936609:624,446...664,049
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936487:13,348,465...13,352,717
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
protein:altered localization:liver (rat) |
RGD |
PMID:12376827 |
RGD:10059389 |
NCBI chrNW_004936542:7,577,192...7,581,598
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
|
RGD |
PMID:31121248 |
RGD:14985250 |
NCBI chrNW_004936483:15,845,777...15,864,341
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32289347 |
|
NCBI chrNW_004936843:595,237...649,390
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12153990 PMID:21245496 PMID:30013034 |
RGD:14975100 |
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23639586 PMID:25226513 |
|
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Il11 |
interleukin 11 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11421492 |
|
NCBI chrNW_004936886:617,531...620,661
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19633216 PMID:24949944 |
|
NCBI chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19164858 |
|
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8218930 |
|
NCBI chrNW_004936783:1,210,715...1,218,315
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:19164858 PMID:23102243 PMID:28138970 PMID:29091898 PMID:29278859 PMID:31077717 PMID:31342809 More...
|
RGD:13793380 RGD:14975281 RGD:15036799 RGD:15090820 RGD:7204421 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936713:679,680...716,801
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15122762 PMID:16212920 PMID:23375450 |
|
NCBI chrNW_004936545:6,227,118...6,231,745
|
|
G |
Il6 |
interleukin 6 |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:7532385 PMID:15763341 PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936549:7,015,595...7,016,246
|
|
G |
Immt |
inner membrane mitochondrial protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936712:1,257,427...1,301,045
|
|
G |
Irak1 |
interleukin 1 receptor associated kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936809:891,407...900,311
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936577:3,896,455...4,198,396
|
|
G |
Keap1 |
kelch like ECH associated protein 1 |
|
ISO |
|
RGD |
PMID:18417483 |
RGD:6893370 |
NCBI chrNW_004936659:785,059...793,775
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12594235 |
|
NCBI chrNW_004936507:5,566,144...5,650,412
|
|
G |
Kng1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:30685357 |
|
NCBI chrNW_004936578:3,255,335...3,281,296
|
|
G |
Krt18 |
keratin 18 |
|
ISO |
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:17340120 PMID:19783637 PMID:33483742 |
RGD:18337498 |
NCBI chrNW_004936512:10,290,706...10,294,647
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936512:10,247,049...10,254,748
|
|
G |
Lap3 |
leucine aminopeptidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936477:10,596,610...10,627,149
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20362651 PMID:20623750 |
|
NCBI chrNW_004936487:15,721,752...15,725,396
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461450 |
|
NCBI chrNW_004936697:20,861...38,568
|
|
G |
LOC101956757 |
neuronal regeneration related protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936531:6,077,691...6,105,517
|
|
G |
LOC101958062 |
glutathione S-transferase A4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936476:7,873,218...7,888,301
|
|
G |
LOC101958900 |
glutathione S-transferase Mu 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936704:1,142,990...1,150,491
|
|
G |
LOC101958966 |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936561:3,017,471...3,035,481
|
|
G |
LOC101959495 |
PZP alpha-2-macroglobulin like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936870:497,071...542,364
|
|
G |
LOC101960095 |
antileukoproteinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936514:7,618,382...7,620,790
|
|
G |
LOC101961588 |
cytochrome P450 2D17 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:27490558 |
RGD:14700879 |
NCBI chrNW_004936718:153,340...157,966
|
|
G |
LOC101961662 |
biotinidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15469856 |
|
NCBI chrNW_004936473:2,787,386...2,823,014
|
|
G |
LOC101962856 |
ceruloplasmin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936519:6,431,156...6,473,183
|
|
G |
LOC101966596 |
dehydrogenase/reductase SDR family member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936495:4,341,261...4,358,279
|
|
G |
LOC101966907 |
histone H2AX |
treatment |
ISO |
|
RGD |
PMID:23265463 |
RGD:8693741 |
NCBI chrNW_004936542:4,046,930...4,049,017
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25143335 |
RGD:25671447 |
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
G |
LOC101969148 |
cytochrome P450 1A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33814510 |
|
NCBI chrNW_004936471:33,682,730...33,688,332
|
|
G |
LOC101969421 |
cytochrome P450 1A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28762043 |
|
NCBI chrNW_004936471:33,704,616...33,709,455
|
|
G |
LOC101969640 |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936740:885,855...888,854
|
|
G |
LOC101970101 |
cytochrome P450 1B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33814510 |
|
NCBI chrNW_004936663:345,021...355,188
|
|
G |
LOC101970144 |
purine nucleoside phosphorylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936877:686,539...692,832
|
|
G |
LOC101970597 |
sulfotransferase 1C1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936729:1,783,124...1,796,723
|
|
G |
LOC101970831 |
serotransferrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936529:6,917,762...6,947,512
|
|
G |
LOC101972117 |
hepcidin antimicrobial peptide |
|
ISO |
mRNA:increased expression:hepatocyte |
RGD |
PMID:24373749 |
RGD:11041724 |
NCBI chrNW_004936570:1,009,344...1,010,654
|
|
G |
LOC101972766 |
tubulin alpha-1A chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936512:6,959,656...6,964,299
|
|
G |
LOC101973017 |
corticosteroid-binding globulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936733:2,141,484...2,148,129
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
treatment |
ISO |
DNA:hypermethylation:promoter CTD Direct Evidence: marker/mechanism associated with Endotoxemia |
RGD CTD |
PMID:12668988 PMID:16770646 PMID:21741958 PMID:25681370 PMID:27324775 PMID:27490558 PMID:27960551 PMID:28762043 PMID:29404441 More...
|
RGD:14700872 RGD:14700873 RGD:14700878 RGD:14700879 RGD:14700901 |
NCBI chrNW_004936486:19,691,822...19,702,684
|
|
G |
LOC101976131 |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18779383 |
|
NCBI chrNW_004936487:3,399,792...3,412,088
|
|
G |
LOC101977223 |
7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25448281 |
|
NCBI chrNW_004936695:2,263,868...2,265,373
|
|
G |
LOC101977655 |
glutamate--cysteine ligase regulatory subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936537:5,356,914...5,378,998
|
|
G |
LOC101978323 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial |
|
ISO |
mRNA, protein:decreased expression:kidney (mouse) |
RGD |
PMID:26476181 |
RGD:25671412 |
NCBI chrNW_004936646:1,899,686...1,904,104
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
ISO |
|
RGD |
PMID:27071702 |
RGD:13794380 |
NCBI chrNW_004936555:4,084,099...4,108,219
|
|
G |
Lrat |
lecithin retinol acyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936576:1,491,480...1,498,568
|
|
G |
Ltb4r |
leukotriene B4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28487374 |
|
NCBI chrNW_004936722:232,320...233,802
|
|
G |
Ltf |
lactotransferrin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16141546 |
|
NCBI chrNW_004936596:344,287...373,788
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18700144 |
|
NCBI chrNW_004936560:3,988,696...4,197,953
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936716:126,628...142,986
|
|
G |
Mccc1 |
methylcrotonyl-CoA carboxylase subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936566:409,558...468,898
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936491:8,570,472...8,586,914
|
|
G |
Me1 |
malic enzyme 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936510:7,425,983...7,571,090
|
|
G |
Med1 |
mediator complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16109766 |
|
NCBI chrNW_004936490:14,625,201...14,663,184
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15763341 |
|
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Mst1 |
macrophage stimulating 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936529:1,298,853...1,306,088
|
|
G |
Mst1r |
macrophage stimulating 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22575169 |
|
NCBI chrNW_004936529:1,494,748...1,509,925
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
treatment |
ISO |
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18551038 PMID:19648163 PMID:30545275 |
RGD:14696733 |
NCBI chrNW_004936474:623,438...637,849
|
|
G |
Mtpn |
myotrophin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936592:644,618...679,615
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
ameliorates |
ISO |
|
RGD |
PMID:17615358 |
RGD:150521532 |
NCBI chrNW_004936473:27,672,237...27,676,339
|
|
G |
Ndufs3 |
NADH:ubiquinone oxidoreductase core subunit S3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936562:1,667,780...1,674,670
|
|
G |
Nfatc4 |
nuclear factor of activated T cells 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:34192554 |
|
NCBI chrNW_004936722:178,866...187,847
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
ISO |
CTD Direct Evidence: therapeutic induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620) |
RGD CTD |
PMID:18417483 PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:29091898 PMID:30215777 PMID:31889292 PMID:31927046 PMID:31972209 PMID:32066295 More...
|
RGD:15090820 RGD:21201280 RGD:21201283 RGD:21201305 RGD:21201308 RGD:6893370 |
NCBI chrNW_004936509:6,589,967...6,621,171
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
treatment susceptibility |
ISO |
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human) |
RGD |
PMID:29091898 PMID:31490979 |
RGD:15090820 RGD:40902984 |
NCBI chrNW_004936520:733,760...850,563
|
|
G |
Nfxl1 |
nuclear transcription factor, X-box binding like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936482:14,008,825...14,062,654
|
|
G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936490:10,634,788...10,640,182
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30394310 |
|
NCBI chrNW_004936669:1,292,016...1,334,061
|
|
G |
Nox4 |
NADPH oxidase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936736:230,465...394,859
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
|
RGD |
PMID:28472605 PMID:28522909 PMID:29091898 |
RGD:13439737 RGD:13439739 RGD:15090820 |
NCBI chrNW_004936475:19,771,384...19,785,034
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0 group B member 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29943110 |
|
NCBI chrNW_004936474:11,316,857...11,319,669
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1 group D member 1 |
treatment |
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chrNW_004936490:15,206,194...15,213,858
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1 group H member 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17256725 |
|
NCBI chrNW_004936562:1,937,665...1,946,680
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
severity treatment |
ISO |
mRNA:decreased expression:liver (rat) CTD Direct Evidence: marker/mechanism protein:decreased expression:liver (rat) |
RGD CTD |
PMID:12875239 PMID:20573685 PMID:22711662 PMID:28827769 PMID:29091898 PMID:30068870 More...
|
RGD:14701035 RGD:14701036 RGD:15042870 RGD:15045609 RGD:15090820 |
NCBI chrNW_004936492:13,315,265...13,365,186
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1 group I member 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human) |
CTD RGD |
PMID:19797606 PMID:28058446 PMID:31490979 |
RGD:40902984 |
NCBI chrNW_004936536:6,691,590...6,726,421
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1 group I member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:14742670 PMID:25656644 PMID:28058446 |
|
NCBI chrNW_004936903:527,838...533,930
|
|
G |
Nr2f2 |
nuclear receptor subfamily 2 group F member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936483:6,886,447...6,900,986
|
|
G |
Nr5a2 |
nuclear receptor subfamily 5 group A member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29515023 |
|
NCBI chrNW_004936567:4,084,161...4,194,858
|
|
G |
Nus1 |
NUS1 dehydrodolichyl diphosphate synthase subunit |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33812996 |
|
NCBI chrNW_004936658:695,431...718,891
|
|
G |
Ociad1 |
OCIA domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936482:14,780,284...14,805,718
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936478:19,506,845...19,584,411
|
|
G |
P4hb |
prolyl 4-hydroxylase subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936594:5,368,199...5,379,215
|
|
G |
Pah |
phenylalanine hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936492:11,342,566...11,412,323
|
|
G |
Pan2 |
poly(A) specific ribonuclease subunit PAN2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936646:719,821...737,284
|
|
G |
Panx1 |
pannexin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29246445 |
|
NCBI chrNW_004936674:736,911...773,406
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936623:2,422,780...2,436,817
|
|
G |
Pc |
pyruvate carboxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936599:2,677,770...2,793,033
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936543:653,844...659,905
|
|
G |
Pcyt1a |
phosphate cytidylyltransferase 1A, choline |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936784:884,751...938,901
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:21182459 PMID:31809757 |
|
NCBI chrNW_004936585:4,701,012...4,713,421
|
|
G |
Pdlim5 |
PDZ and LIM domain 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936687:1,944,095...2,152,501
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936483:15,474,484...15,480,527
|
|
G |
Pgm1 |
phosphoglucomutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936692:1,160,836...1,221,270
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chrNW_004936785:476,200...503,371
|
|
G |
Plg |
plasminogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22507835 |
|
NCBI chrNW_004936489:11,775,243...11,808,482
|
|
G |
Pls3 |
plastin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936499:246,042...335,440
|
|
G |
Pnrc1 |
proline rich nuclear receptor coactivator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936510:3,109,114...3,112,616
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
no_association susceptibility |
ISO |
DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human) CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) |
RGD CTD |
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931 |
RGD:15039297 RGD:15039302 |
NCBI chrNW_004936483:15,178,947...15,196,277
|
|
G |
Polr2g |
RNA polymerase II subunit G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936581:523,018...528,167
|
|
G |
Pon1 |
paraoxonase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936585:4,954,871...4,979,560
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
LPS-induced acute liver damage CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21262334 PMID:24385052 |
RGD:5509941 |
NCBI chrNW_004936629:3,672,445...3,725,645
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:26599535 |
RGD:11554658 |
NCBI chrNW_004936602:1,230,907...1,368,588
|
|
G |
Pptc7 |
protein phosphatase targeting COQ7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936558:3,491,225...3,531,886
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
treatment |
ISO |
|
RGD |
PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936518:1,817,051...1,843,376
|
|
G |
Prkcd |
protein kinase C delta |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:30393195 |
|
NCBI chrNW_004936473:3,892,625...3,923,467
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224054 |
|
NCBI chrNW_004936590:4,722,914...4,887,615
|
|
G |
Ptf1a |
pancreas associated transcription factor 1a |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21182459 |
|
NCBI chrNW_004936520:4,978,896...4,980,648
|
|
G |
Ptges2 |
prostaglandin E synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31444509 |
|
NCBI chrNW_004936487:15,703,179...15,708,408
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
treatment |
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:11743745 PMID:29091898 |
RGD:15090820 |
NCBI chrNW_004936481:3,821,564...3,828,086
|
|
G |
Pum1 |
pumilio RNA binding family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936474:14,243,325...14,363,461
|
|
G |
Pygl |
glycogen phosphorylase L |
|
ISO |
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:25231249 PMID:25336395 |
RGD:21079733 |
NCBI chrNW_004936495:14,692,688...14,728,663
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936469:5,839,560...5,933,049
|
|
G |
Rbp1 |
retinol binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936540:1,600,673...1,626,573
|
|
G |
Rdh13 |
retinol dehydrogenase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27865848 |
|
NCBI chrNW_004936886:356,068...368,525
|
|
G |
Reep5 |
receptor accessory protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936531:7,055,841...7,103,810
|
|
G |
Rgn |
regucalcin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936502:12,872,938...12,891,270
|
|
G |
Ripk3 |
receptor interacting serine/threonine kinase 3 |
|
ISO |
CTD Direct Evidence: therapeutic protein:increased expression:liver (mouse) |
CTD RGD |
PMID:26769846 PMID:28205631 |
RGD:127229945 |
NCBI chrNW_004936722:209,019...212,817
|
|
G |
Selenbp1 |
selenium binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936580:1,573,208...1,584,266
|
|
G |
Sema4a |
semaphorin 4A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33290778 |
|
NCBI chrNW_004936580:5,404,380...5,431,183
|
|
G |
Senp2 |
SUMO specific peptidase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:29535048 |
|
NCBI chrNW_004936578:4,252,718...4,290,452
|
|
G |
Serpine1 |
serpin family E member 1 |
treatment |
ISO |
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) |
RGD |
PMID:23183238 |
RGD:14696750 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
G |
Serping1 |
serpin family G member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936581:4,911,403...4,924,484
|
|
G |
Sesn2 |
sestrin 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28209544 |
|
NCBI chrNW_004936474:12,416,652...12,436,799
|
|
G |
Sgf29 |
SAGA complex associated factor 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936501:12,008,601...12,024,113
|
|
G |
Shc1 |
SHC adaptor protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 PMID:32659284 |
|
NCBI chrNW_004936580:4,511,560...4,522,003
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
|
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:28827769 |
RGD:15045609 |
NCBI chrNW_004936495:12,958,983...12,975,755
|
|
G |
Slc10a7 |
solute carrier family 10 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936535:2,792,576...3,038,504
|
|
G |
Slc13a4 |
solute carrier family 13 member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936592:450,237...497,050
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936581:319,372...343,171
|
|
G |
Slc25a29 |
solute carrier family 25 member 29 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936604:3,950,266...3,965,836
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
treatment |
ISO |
|
RGD |
PMID:9200186 |
RGD:151357001 |
NCBI chrNW_004936641:1,513,110...1,538,955
|
|
G |
Snx18 |
sorting nexin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936480:13,108,510...13,137,550
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 PMID:27349771 |
|
NCBI chrNW_004936500:10,345,154...10,352,873
|
|
G |
Sod2 |
superoxide dismutase 2 |
severity treatment susceptibility |
ISO |
associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) DNA:SNP:cds:p.Val16Ala(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19332662 PMID:19647030 PMID:20578157 PMID:25226513 PMID:27019981 |
RGD:11060605 RGD:26923957 RGD:26923959 RGD:26923961 |
NCBI chrNW_004936489:11,178,338...11,191,601
|
|
G |
Sord |
sorbitol dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12763371 |
|
NCBI chrNW_004936471:7,760,097...7,805,475
|
|
G |
Sorl1 |
sortilin related receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936542:6,192,407...6,352,835
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20623750 |
|
NCBI chrNW_004936905:148,956...156,023
|
|
G |
Srp72 |
signal recognition particle 72 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936482:18,687,088...18,721,734
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
severity |
ISO |
protein:increased phosphorylation:liver, inflammatory cell (mouse) mRNA:increased expression:liver, macrophage (mouse) |
RGD |
PMID:23876342 PMID:24731448 |
RGD:25671417 RGD:25671422 |
NCBI chrNW_004936506:7,091,982...7,185,938
|
|
G |
Sult2b1 |
sulfotransferase family 2B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27052460 |
|
NCBI chrNW_004936664:2,626,810...2,655,290
|
|
G |
Suox |
sulfite oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936646:411,543...415,709
|
|
G |
Tagln2 |
transgelin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936740:689,745...697,145
|
|
G |
Taldo1 |
transaldolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19436114 |
|
NCBI chrNW_004936888:531,002...540,194
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22206755 |
|
NCBI chrNW_004936588:2,040,712...2,044,635
|
|
G |
Tctn1 |
tectonic family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17984051 |
|
NCBI chrNW_004936558:3,552,909...3,581,212
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:27516150 |
RGD:14995464 |
NCBI chrNW_004936661:3,742,080...3,758,266
|
|
G |
Tgfbr1 |
transforming growth factor beta receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28560358 |
|
NCBI chrNW_004936524:7,656,523...7,680,043
|
|
G |
Thpo |
thrombopoietin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:33122006 |
|
NCBI chrNW_004936578:5,508,669...5,515,984
|
|
G |
Tlr4 |
toll like receptor 4 |
disease_progression |
ISO |
|
RGD |
PMID:17504260 |
RGD:14697733 |
NCBI chrNW_004936487:6,519,140...6,532,018
|
|
G |
Tlr5 |
toll like receptor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30508503 |
|
NCBI chrNW_004936526:383,490...387,007
|
|
G |
Tmed7 |
transmembrane p24 trafficking protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936742:779,964...791,738
|
|
G |
Tmem117 |
transmembrane protein 117 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936512:2,327,765...2,765,488
|
|
G |
Tmem164 |
transmembrane protein 164 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936499:5,042,638...5,199,433
|
|
G |
Tmem38b |
transmembrane protein 38B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936559:6,501,890...6,553,446
|
|
G |
Tnf |
tumor necrosis factor |
treatment severity |
ISO |
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism|therapeutic |
RGD CTD |
PMID:7532385 PMID:9309314 PMID:9696492 PMID:10801287 PMID:10801288 PMID:11124822 PMID:14686721 PMID:15830285 PMID:17070847 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482 PMID:29091898 PMID:31077717 PMID:31342809 More...
|
RGD:10450531 RGD:14696804 RGD:14975281 RGD:14995429 RGD:14995432 RGD:14995435 RGD:14995437 RGD:14995485 RGD:15036799 RGD:15090820 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Trpm2 |
transient receptor potential cation channel subfamily M member 2 |
|
ISO |
|
RGD |
PMID:24569808 |
RGD:9999438 |
NCBI chrNW_004936500:21,960...76,895
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16099942 |
|
NCBI chrNW_004936682:1,628,489...1,635,495
|
|
G |
Tubb4b |
tubulin beta 4B class IVb |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936669:749,203...751,622
|
|
G |
Uba5 |
ubiquitin like modifier activating enzyme 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004936529:5,997,459...6,010,776
|
|
G |
Unc93b1 |
unc-93 homolog B1, TLR signaling regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936599:2,109,292...2,146,006
|
|
G |
Usp5 |
ubiquitin specific peptidase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936709:952,225...966,429
|
|
G |
Vegfa |
vascular endothelial growth factor A |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17784864 PMID:25231249 |
RGD:15003197 |
NCBI chrNW_004936476:16,245,134...16,261,180
|
|
G |
Vim |
vimentin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936520:10,051,692...10,059,324
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:liver: |
CTD RGD |
PMID:7531171 PMID:28527913 |
RGD:11079232 |
NCBI chrNW_004936709:1,578,137...1,741,877
|
|
G |
Wasl |
WASP like actin nucleation promoting factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936605:1,741,832...1,816,694
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
susceptibility |
ISO |
DNA:haploinsufficiency: : (mouse) |
RGD |
PMID:21737425 |
RGD:15036796 |
NCBI chrNW_004936706:752,571...783,746
|
|
G |
Xylb |
xylulokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231249 |
|
NCBI chrNW_004936473:27,725,955...27,767,319
|
|
G |
Zdhhc23 |
zinc finger DHHC-type palmitoyltransferase 23 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25226513 |
|
NCBI chrNW_004936536:1,434,774...1,450,872
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20216337 |
|
NCBI chrNW_004936636:292,631...341,999
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19019667 |
|
NCBI chrNW_004936567:1,430,128...1,508,626
|
|
G |
Adora2a |
adenosine A2a receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19019667 |
|
NCBI chrNW_004936619:597,970...618,564
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14616128 |
|
NCBI chrNW_004936543:2,400,743...2,403,558
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16630147 |
|
NCBI chrNW_004936547:479,261...504,757
|
|
G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15970796 |
|
NCBI chrNW_004936565:1,917,970...1,919,027
|
|
G |
Faslg |
Fas ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19706026 |
|
NCBI chrNW_004936481:14,789,547...14,795,780
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17125826 PMID:20485159 |
|
NCBI chrNW_004936740:1,201,370...1,206,871
|
|
G |
Fcer1g |
Fc fragment of IgE receptor Ig |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18534082 PMID:18595682 |
|
NCBI chrNW_004936903:514,278...517,975
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism associated with Acquired Immunodeficiency Syndrome;DNA:polymorphism:exon:A>G313 (rs1695) (human) |
CTD RGD |
PMID:16297214 PMID:20485159 |
RGD:5490995 |
NCBI chrNW_004936599:2,197,681...2,200,642
|
|
G |
Hnmt |
histamine N-methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004936469:38,125,877...38,166,429
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19222424 PMID:20485159 |
|
NCBI chrNW_004936557:5,834,874...5,838,502
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004936647:2,529,933...2,532,503
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:1549655 |
RGD:8662975 |
NCBI chrNW_004936662:1,594,953...1,599,625
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20485159 |
|
NCBI chrNW_004936501:11,025,590...11,058,807
|
|
G |
LOC101956126 |
heat shock 70 kDa protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16538175 |
|
NCBI chrNW_004936727:1,732,323...1,735,128
|
|
G |
LOC101956412 |
heat shock 70 kDa protein 1-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16538175 |
|
NCBI chrNW_004936727:1,735,880...1,745,231
|
|
G |
LOC101968920 |
eotaxin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14616128 |
|
NCBI chrNW_004936538:835,436...848,907
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18727619 |
|
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
G |
Ltc4s |
leukotriene C4 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16433794 |
|
NCBI chrNW_004936739:975,494...978,426
|
|
G |
Mln |
motilin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16538176 |
|
NCBI chrNW_004936476:25,141,317...25,165,161
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16839402 PMID:18534082 PMID:20485159 |
|
NCBI chrNW_004936581:2,743,133...2,751,925
|
|
G |
Nlrp3 |
NLR family pyrin domain containing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19767079 |
|
NCBI chrNW_004936864:709,693...732,119
|
|
G |
Postn |
periostin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18391768 |
|
NCBI chrNW_004936472:31,644,778...31,677,572
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20587336 |
|
NCBI chrNW_004936591:1,174,364...1,250,233
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17508966 |
|
NCBI chrNW_004936487:10,745,465...10,758,812
|
|
G |
Tac1 |
tachykinin precursor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21233199 |
|
NCBI chrNW_004936585:2,932,783...2,941,141
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21449675 |
|
NCBI chrNW_004936592:4,038,163...4,192,772
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11294926 PMID:20485159 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004936554:7,807,914...7,848,691
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chrNW_004936542:2,111,055...2,112,626
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chrNW_004936706:1,531,219...1,531,921
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chrNW_004936542:2,106,927...2,108,412
|
|
G |
Bdnf |
brain derived neurotrophic factor |
|
ISO |
mRNA:increased expression:lymph node, ear: |
RGD |
PMID:19904815 |
RGD:8657071 |
NCBI chrNW_004936540:5,530,081...5,582,765
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004936740:1,201,370...1,206,871
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chrNW_004936476:8,621,860...8,625,008
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18204966 |
|
NCBI chrNW_004936612:2,306,963...2,325,086
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chrNW_004936662:1,594,953...1,599,625
|
|
G |
Kng1 |
kininogen 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:1371395 PMID:3034372 |
|
NCBI chrNW_004936578:3,255,335...3,281,296
|
|
G |
LOC101963197 |
HLA class II histocompatibility antigen, DP beta 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16502481 |
|
NCBI chrNW_004936476:25,730,800...25,741,089
|
|
G |
LOC101969148 |
cytochrome P450 1A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19351467 |
|
NCBI chrNW_004936471:33,682,730...33,688,332
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19351467 |
|
NCBI chrNW_004936486:19,691,822...19,702,684
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18204966 |
|
NCBI chrNW_004936490:4,809,773...4,819,070
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14723717 |
|
NCBI chrNW_004936474:623,438...637,849
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chrNW_004936599:3,800,142...3,810,583
|
|
G |
Tac1 |
tachykinin precursor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1371395 |
|
NCBI chrNW_004936585:2,932,783...2,941,141
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31150805 |
|
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Ttr |
transthyretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21055120 |
|
NCBI chrNW_004936682:1,628,489...1,635,495
|
|
|
G |
C1qa |
complement C1q A chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936474:8,007,953...8,010,591
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
DNA:SNP:promoter:-511C>T (rs 16944) (human) |
RGD |
PMID:23461376 |
RGD:11051970 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
DNA:SNP:intron:rs2234663 (human) |
RGD |
PMID:23461376 |
RGD:11051970 |
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
LOC101956412 |
heat shock 70 kDa protein 1-like |
|
ISO |
DNA:polymorphism, haplotype: :p.M493T (human) |
RGD |
PMID:15024131 |
RGD:8662461 |
NCBI chrNW_004936727:1,735,880...1,745,231
|
|
G |
LOC101958966 |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936561:3,017,471...3,035,481
|
|
G |
LOC101960229 |
complement C1q subcomponent subunit C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936474:8,013,395...8,016,937
|
|
G |
LOC101969640 |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936740:885,855...888,854
|
|
G |
Lrg1 |
leucine rich alpha-2-glycoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936588:2,638,597...2,640,856
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936709:1,578,137...1,741,877
|
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
|
ISO |
|
RGD |
PMID:6445277 PMID:7740056 |
RGD:10047091 RGD:1598524 |
NCBI chrNW_004936530:7,543,743...7,621,392
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
|
ISO |
|
RGD |
PMID:18947822 |
RGD:6906919 |
NCBI chrNW_004936473:4,164,633...4,479,866
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19109989 |
|
NCBI chrNW_004936533:3,601,270...3,637,128
|
|
G |
Cck |
cholecystokinin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:2320253 |
|
NCBI chrNW_004936695:2,776,705...2,782,280
|
|
G |
Comt |
catechol-O-methyltransferase |
|
ISO |
|
RGD |
PMID:16437585 |
RGD:2289781 |
NCBI chrNW_004936619:3,847,059...3,883,866
|
|
G |
Dbn1 |
drebrin 1 |
|
ISO |
levodopainduced; protein:increased expression:striatum: |
RGD |
PMID:23241013 |
RGD:10398811 |
NCBI chrNW_004936597:1,735,589...1,751,628
|
|
G |
Ddc |
dopa decarboxylase |
|
ISO |
associated with Parkinson Disease; protein:decreased expression:striatum (rat) |
RGD |
PMID:20232137 |
RGD:5128860 |
NCBI chrNW_004936686:1,322,153...1,405,434
|
|
G |
Drd1 |
dopamine receptor D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364 |
|
NCBI chrNW_004936609:790,647...795,187
|
|
G |
Drd2 |
dopamine receptor D2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801 |
RGD:2311579 |
NCBI chrNW_004936612:1,094,686...1,154,149
|
|
G |
Drd3 |
dopamine receptor D3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20945430 |
|
NCBI chrNW_004936536:1,580,732...1,616,726
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
|
RGD |
PMID:22153973 |
RGD:10395307 |
NCBI chrNW_004936531:7,625,956...7,629,041
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17219962 |
|
NCBI chrNW_004936706:1,900,954...1,907,567
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9767399 |
|
NCBI chrNW_004936509:1,160,559...1,201,037
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15659429 |
|
NCBI chrNW_004936697:232,048...275,420
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11168568 |
|
NCBI chrNW_004936518:4,291,391...4,310,752
|
|
G |
Glul |
glutamate-ammonia ligase |
|
ISO |
|
RGD |
PMID:6445277 |
RGD:10047091 |
NCBI chrNW_004936481:7,293,301...7,301,416
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
|
ISO |
associated with Parkinson Disease |
RGD |
PMID:20410529 |
RGD:5684919 |
NCBI chrNW_004936597:1,706,671...1,722,370
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:26997328 |
RGD:13792768 |
NCBI chrNW_004936536:6,730,070...6,893,818
|
|
G |
Homer1 |
homer scaffold protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24126708 |
|
NCBI chrNW_004936549:7,189,588...7,320,117
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
|
ISO |
|
RGD |
PMID:21352823 |
RGD:5683628 |
NCBI chrNW_004936480:5,042,531...5,047,157
|
|
G |
LOC101961588 |
cytochrome P450 2D17 |
|
ISO |
|
RGD |
PMID:12629505 |
RGD:1358549 |
NCBI chrNW_004936718:153,340...157,966
|
|
G |
Mapt |
microtubule associated protein tau |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:25511986 |
RGD:13800920 |
NCBI chrNW_004936541:2,381,411...2,479,984
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:23938307 |
RGD:10040953 |
NCBI chrNW_004936474:158,376...282,310
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9767399 PMID:21737418 |
|
NCBI chrNW_004936485:16,559,371...16,571,461
|
|
G |
Penk |
proenkephalin |
|
ISO |
mRNA:increased expression:brain:striatum: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9767399 PMID:20456008 |
RGD:10003039 |
NCBI chrNW_004936496:3,016,247...3,021,726
|
|
G |
Ppp1r1b |
protein phosphatase 1 regulatory inhibitor subunit 1B |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:27771532 |
RGD:13514053 |
NCBI chrNW_004936490:14,822,246...14,831,337
|
|
G |
Rasgrf1 |
Ras protein specific guanine nucleotide releasing factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21115823 |
|
NCBI chrNW_004936471:37,173,595...37,278,356
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
protein:increased expression:nucleus, brain |
RGD |
PMID:18590723 |
RGD:2298778 |
NCBI chrNW_004936599:3,800,142...3,810,583
|
|
G |
Rgs4 |
regulator of G protein signaling 4 |
treatment |
ISO |
associated with Parkinsonian Disorders |
RGD |
PMID:24969021 |
RGD:13524515 |
NCBI chrNW_004937238:101,948...109,513
|
|
G |
Rgs9 |
regulator of G protein signaling 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:18160641 PMID:24663062 |
|
NCBI chrNW_004936541:7,472,195...7,525,220
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15659429 |
|
NCBI chrNW_004936794:478,651...486,887
|
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
ISO |
|
RGD |
PMID:29064425 |
RGD:13450913 |
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
no_association susceptibility |
ISO |
DNA:SNPs:multiple: DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human) |
RGD |
PMID:17502832 PMID:22178260 |
RGD:14700816 RGD:14700817 |
NCBI chrNW_004936636:292,631...341,999
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
ISO |
|
RGD |
PMID:16140414 |
RGD:2316848 |
NCBI chrNW_004936549:1,378,536...1,400,501
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:23619520 |
RGD:14700910 |
NCBI chrNW_004936486:19,691,822...19,702,684
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
|
ISO |
protein:increased expression:liver (mouse) |
RGD |
PMID:12201952 |
RGD:10054288 |
NCBI chrNW_004936559:2,187,791...2,331,587
|
|
|
G |
C3 |
complement C3 |
|
ISO |
associated with Leprosy |
RGD |
PMID:2783924 |
RGD:7421527 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Cfb |
complement factor B |
|
ISO |
associated with Leprosy |
RGD |
PMID:2783924 |
RGD:7421527 |
NCBI chrNW_004936727:1,595,872...1,602,274
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
associated with Sarcoidosis;DNA:polymorphism:intron |
RGD |
PMID:19225544 |
RGD:8548773 |
NCBI chrNW_004936727:1,940,081...1,941,022
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility |
ISO |
associated with Inflammatory Bowel Diseases;DNA:polymorphisms: :-1031T>C(human) |
RGD |
PMID:12198697 |
RGD:7364926 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Vdr |
vitamin D receptor |
susceptibility |
ISO |
associated with Behcet Syndrome;DNA:polymorphism: : rs7975232(human) |
RGD |
PMID:24880677 |
RGD:13217417 |
NCBI chrNW_004936512:5,741,836...5,800,999
|
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
treatment |
ISO |
|
RGD |
PMID:28921207 |
RGD:14975164 |
NCBI chrNW_004936470:7,765,810...7,770,837
|
|
|
G |
Kdr |
kinase insert domain receptor |
treatment |
ISO |
DNA:polymorphism:cds:p.H472Q(human) |
RGD |
PMID:20630084 |
RGD:8552374 |
NCBI chrNW_004936482:17,537,697...17,581,320
|
|
|
G |
Casp9 |
caspase 9 |
|
ISO |
|
RGD |
PMID:25014874 |
RGD:13782349 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
treatment |
ISO |
|
RGD |
PMID:11991626 |
RGD:10003093 |
NCBI chrNW_004936591:1,174,364...1,250,233
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
treatment |
ISO |
|
RGD |
PMID:11991626 |
RGD:10003093 |
NCBI chrNW_004936518:1,903,636...1,916,746
|
|
|
G |
Tpmt |
thiopurine S-methyltransferase |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936552:3,899,445...3,917,774
|
|
|
G |
Nudt15 |
nudix hydrolase 15 |
|
ISO |
ClinVar Annotator: match by term: Thiopurines, poor metabolism of, 2 |
OMIM ClinVar |
PMID:22992668 PMID:25108385 PMID:25624441 PMID:26033531 PMID:26076924 PMID:26405151 PMID:26503813 PMID:26590936 PMID:26735160 PMID:26878724 PMID:27095468 PMID:27193222 PMID:27416873 PMID:27558924 PMID:27577869 PMID:27604507 PMID:28088792 PMID:28146264 PMID:28418010 PMID:28445187 PMID:28659275 PMID:29702976 PMID:29704867 PMID:29720126 PMID:29867468 PMID:29923122 PMID:29967377 PMID:30035323 PMID:30048756 PMID:30101994 PMID:30728528 PMID:31024313 More...
|
|
NCBI chrNW_004936565:1,380,981...1,389,908
|
|
|
G |
Cabp1 |
calcium binding protein 1 |
|
ISO |
protein:altered expression:postsynaptic density |
RGD |
PMID:19224364 |
RGD:14399959 |
NCBI chrNW_004936668:324,299...339,334
|
|
|
G |
Apcs |
amyloid P component, serum |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936740:979,007...987,312
|
|
G |
C1qa |
complement C1q A chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936474:8,007,953...8,010,591
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936589:2,504,235...2,536,778
|
|
G |
Celf2 |
CUGBP Elav-like family member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936484:3,904,726...4,401,560
|
|
G |
Clu |
clusterin |
|
ISO |
mRNA:decreased expression:conjunctiva |
RGD |
PMID:12036968 |
RGD:8699507 |
NCBI chrNW_004936675:499,745...513,515
|
|
G |
Cops5 |
COP9 signalosome subunit 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936496:7,035,973...7,050,538
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11321886 |
|
NCBI chrNW_004936490:15,142,526...15,146,375
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936473:29,999,542...30,034,610
|
|
G |
Cul1 |
cullin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936527:4,971,002...5,019,465
|
|
G |
Cul4a |
cullin 4A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936472:409,083...432,442
|
|
G |
Derl1 |
derlin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936470:24,262,401...24,286,713
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936478:12,308,255...12,754,957
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936492:696,982...778,132
|
|
G |
Fbxo6 |
F-box protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936474:531,873...538,596
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936545:6,139,130...6,144,543
|
|
G |
LOC101958966 |
lipopolysaccharide binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936561:3,017,471...3,035,481
|
|
G |
LOC101960229 |
complement C1q subcomponent subunit C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936474:8,013,395...8,016,937
|
|
G |
LOC101961626 |
complement factor properdin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936502:13,391,613...13,398,723
|
|
G |
LOC101969640 |
C-reactive protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936740:885,855...888,854
|
|
G |
LOC101972576 |
valosin containing protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936524:3,085,959...3,102,461
|
|
G |
Lrg1 |
leucine rich alpha-2-glycoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936588:2,638,597...2,640,856
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9372356 |
|
NCBI chrNW_004936619:1,207,058...1,208,010
|
|
G |
Nedd4 |
NEDD4 E3 ubiquitin protein ligase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936471:17,254,777...17,374,725
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10620138 |
|
NCBI chrNW_004936538:4,052,277...4,097,051
|
|
G |
Nucb1 |
nucleobindin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936664:2,924,186...2,946,035
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936526:3,102,468...3,147,601
|
|
G |
Pml |
PML nuclear body scaffold |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936471:33,135,186...33,173,218
|
|
G |
Pros1 |
protein S |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936666:18,303...110,357
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936541:4,470,210...4,475,233
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21966456 |
|
NCBI chrNW_004936591:1,174,364...1,250,233
|
|
G |
Ptgis |
prostaglandin I2 synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936514:4,775,884...4,814,574
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936565:1,596,227...1,746,706
|
|
G |
Rbx1 |
ring-box 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25811541 |
|
NCBI chrNW_004936492:872,316...890,860
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:blister: |
RGD |
PMID:9852250 |
RGD:7401184 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34142820 |
|
NCBI chrNW_004936709:1,578,137...1,741,877
|
|
|
G |
Drd3 |
dopamine receptor D3 |
|
ISO |
associated with schizophrenia |
RGD |
PMID:12960753 |
RGD:1581250 |
NCBI chrNW_004936536:1,580,732...1,616,726
|
|
G |
LOC101969421 |
cytochrome P450 1A2 |
treatment |
ISO |
associated with schizophrenia |
RGD |
PMID:10889552 |
RGD:1358545 |
NCBI chrNW_004936471:33,704,616...33,709,455
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
associated with schizophrenia |
RGD |
PMID:12960753 |
RGD:1581250 |
NCBI chrNW_004936489:11,178,338...11,191,601
|
|
|
G |
Tpmt |
thiopurine S-methyltransferase |
|
ISO |
ClinVar Annotator: match by term: Thiopurine methyltransferase deficiency |
ClinVar |
PMID:1960624 PMID:7862671 PMID:8561894 PMID:8644731 PMID:9177237 PMID:9246020 PMID:9931345 PMID:9931346 PMID:10208641 PMID:10751626 PMID:15819814 PMID:16476125 PMID:17885628 More...
|
|
NCBI chrNW_004936552:3,899,445...3,917,774
|
|